Astellas Expected To Acquire OSI Of U.S., But At Higher Price
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma is seen as on the way to acquiring U.S.-based OSI Pharmaceuticals, although at a higher price than it had planned